Home/Filings/4/0000950170-24-105200
4//SEC Filing

Warner Douglas J 4

Accession 0000950170-24-105200

CIK 0001863127other

Filed

Sep 9, 8:00 PM ET

Accepted

Sep 10, 4:53 PM ET

Size

5.3 KB

Accession

0000950170-24-105200

Insider Transaction Report

Form 4
Period: 2024-09-09
Warner Douglas J
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-09-09+260,000260,000 total
    Exercise: $21.51Exp: 2034-09-08Common Stock (260,000 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the option shall vest on September 9, 2025, and 1/36th of the remaining number of shares subject to the option vest monthly thereafter, subject to the Reporting Person's continuous service to the Issuer through each vesting date.

Documents

1 file

Issuer

Tyra Biosciences, Inc.

CIK 0001863127

Entity typeother

Related Parties

1
  • filerCIK 0001941311

Filing Metadata

Form type
4
Filed
Sep 9, 8:00 PM ET
Accepted
Sep 10, 4:53 PM ET
Size
5.3 KB